U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Village Pharmacy - 516174 - 02/01/2021
  1. Warning Letters

CLOSEOUT LETTER

Village Pharmacy MARCS-CMS 516174 —

Delivery Method:
Electronic Email
Reference #:
#17-NWJ-10
Product:
Drugs
Recipient:
Recipient Name
Ann Ervin
Recipient Title
Owner
Village Pharmacy

1280 Yardville-Allentown Road
Allentown, NJ 08501-1830
United States

ann@thevillagepharmacy.com
Issuing Office:
New Jersey District Office

United States

(973) 331-4900

Dear Ms. Ervin:

The U.S. Food and Drug Administration (FDA) has completed an evaluation of your firm’s corrective actions in response to our warning letter #17-NWJ-10, dated October 30, 2017. Based on our evaluation, it appears that you have adequately addressed the violations contained in this warning letter.

You are expected to take all necessary steps to ensure compliance with the Federal Food, Drug, and Cosmetic Act and FDA’s implementing regulations. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Sincerely,
/S/
Diana Amador-Toro
Program Division Director/District Director
Office of Pharmaceutical Quality Operations
Division I/New Jersey District Office

Back to Top